Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer
Completed · Phase 1/Phase 2
Conditions studied: Metastatic Cancer, Melanoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Colorectal Cancer
In brief
This study evaluated the safety and efficacy of VE800 in combination with nivolumab in patients with selected types of advanced or metastatic cancer
Key facts
- Study ID
- NCT04208958
- Run by
- Vedanta Biosciences, Inc.
- People needed
- 56
- Starts
- 2020-01-23
- Expected to finish
- 2023-02-23
- Last updated by the study team
- 2025-10-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- HonorHealth Research Institute — Scottsdale, Arizona, United States
- University of California Los Angeles — Los Angeles, California, United States
- Pacific Hematology Oncology Associates — San Francisco, California, United States
- The Angeles Clinic and Research Institute - West Los Angeles Office — Santa Monica, California, United States
- University of California Los Angeles — Santa Monica, California, United States
- Florida Cancer Specialists — Sarasota, Florida, United States
- Moffitt Cancer Center — Tampa, Florida, United States
- The University of Chicago — Chicago, Illinois, United States
- Indiana University Melvin and Bren Simon Cancer Center — Indianapolis, Indiana, United States
- Washington University School of Medicine Siteman Cancer Center — St Louis, Missouri, United States
- John Theurer Cancer Center — Hackensack, New Jersey, United States
- New York University Medical Oncology Associates — New York, New York, United States
- Weill Cornell Medicine — New York, New York, United States
- UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania, United States
- The Miriam Hospital — Providence, Rhode Island, United States
- Baylor Scott and White Center for Advanced Heart and Lung Disese — Dallas, Texas, United States
- Huntsman Cancer Institute and Hospital — Salt Lake City, Utah, United States
- Swedish Medical Oncology - First Hill — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.